These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12899115)

  • 1. Use of psychiatric drugs in Slovenia in comparison to Scandinavian countries.
    Fürst J; Kocmur M
    Pharmacoepidemiol Drug Saf; 2003; 12(5):399-403. PubMed ID: 12899115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing changes in anxiolytics and antidepressants in Slovenia.
    Svab V; Subelj M; Vidmar G
    Psychiatr Danub; 2011 Jun; 23(2):178-82. PubMed ID: 21685857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends in prescribing habits of anxiolytics and antidepressants in Slovenian family practices (with emphasis on elderly patients).
    Subelj M; Vidmar G; Svab V
    Coll Antropol; 2012 Jun; 36(2):483-9. PubMed ID: 22856234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use development of sedatives/hypnotics and psychopharmaceuticals in the DDR with international comparisons using defined daily doses (DDD)].
    Walther H; Meyer FP; Leuschner U
    Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):218-29. PubMed ID: 6114505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient utilization of psychopharmaceuticals: comparison between Croatia and Scandinavian countries (2001-2003).
    Stimac D; Vukusić I; Culig J; Sostar Z; Bucalić M
    Coll Antropol; 2009 Mar; 33(1):237-43. PubMed ID: 19408632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
    Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia.
    Tiger M; Wesselhoeft R; Karlsson P; Handal M; Bliddal M; Cesta CE; Skurtveit S; Reutfors J
    J Affect Disord; 2023 Feb; 323():292-298. PubMed ID: 36442654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the provision of counselling and the prescribing of antidepressants, hypnotics and anxiolytics in general practice.
    Fletcher J; Fahey T; McWilliam J
    Br J Gen Pract; 1995 Sep; 45(398):467-9. PubMed ID: 7546869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consumption of psychotropic drugs in Tunisia].
    Regaieg I; Ridha R; Zghal A; Haffani F
    Tunis Med; 1995 Oct; 73(10):369-72. PubMed ID: 9506160
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurocognitive costs and benefits of psychotropic medications in older adults.
    Brooks JO; Hoblyn JC
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):199-214. PubMed ID: 18004007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swedish company doctors' attitudes to benzodiazepines and neuroleptics used as minor tranquillizers.
    Sällström G; Maasing R
    Pharmatherapeutica; 1980; 2(6):380-6. PubMed ID: 6107934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of psychotropic drugs in Croatia before and during the COVID-19 pandemic: a 10-year longitudinal study (2012-2021).
    Vukićević T; Draganić P; Škribulja M; Puljak L; Došenović S
    Soc Psychiatry Psychiatr Epidemiol; 2024 May; 59(5):799-811. PubMed ID: 37847256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital use of antipsychotic drugs: polytherapy.
    Centorrino F; Cincotta SL; Talamo A; Fogarty KV; Guzzetta F; Saadeh MG; Salvatore P; Baldessarini RJ
    Compr Psychiatry; 2008; 49(1):65-9. PubMed ID: 18063043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of anxiety disorders in the Finnish general population.
    Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
    J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing prescription of CNS medications in different elderly populations.
    Craig D; Passmore AP; Fullerton KJ; Beringer TR; Gilmore DH; Crawford VL; McCaffrey PM; Montgomery A
    Pharmacoepidemiol Drug Saf; 2003; 12(5):383-7. PubMed ID: 12899112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of several psychotropic agents on changes in the behavior of mice induced by acetaldehyde].
    Andronova LM; Barkov NK; Vikhliaev IuI
    Farmakol Toksikol; 1978; 41(6):660-5. PubMed ID: 31298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in antipsychotic drug use in patients with dementia: a nationwide study.
    Nørgaard A; Jensen-Dahm C; Gasse C; Hansen HV; Waldemar G
    J Alzheimers Dis; 2016; 49(1):211-20. PubMed ID: 26444790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Hypnotic' prescription patterns in a large managed-care population.
    Roehrs T; Roth T
    Sleep Med; 2004 Sep; 5(5):463-6. PubMed ID: 15341891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.